Relx PLC

Análisis de la acción Relx PLC (RELX)

$39.060

+0.652 (+1.67%)Al cierre

Loading chart…
Máximo
39.560
Apertura
39.490
Precio medio ponderado por volumen
39.13
Volumen
3.22M
Capitalización
85.96B
Mínimo
38.770
Importe
125.95M
EV/EBITDA, TTM
15.18

RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.

www.relx.com

Análisis de IA of Relx PLC (RELX)

Comprar

RELX PLC is a good buy right now due to its strong revenue growth of 3% year-over-year, a current price of $39.06, and a forward P/E ratio of 15.06, which suggests it is attractively valued compared to its earnings potential. The RSI is at 95.901, indicating strong momentum, while hedge funds are increasing their positions by 147.40%, reflecting positive sentiment. The main risk is the 1-year change of -15.29%, which indicates past underperformance that investors should consider.

Recomendaciones de analistas (1)

+54.99% de potencial alcista
Comprar
1 Comprar
0 Mantener
0 Vender
Actual: 39.06
Mínimo
60.54
Promedio
60.54
Máximo
60.54

BofA

2026-09-29

Precio objetivo

—

Comprar

TD Cowen

2026-09-10

Precio objetivo

—

Comprar

Barclays

2026-07-24

Precio objetivo

—

Sobreponderar

BofA

2026-07-24

Precio objetivo

—

Comprar

Morgan Stanley

2026-05-07

Precio objetivo

—

Equal Weight

Métricas de valoración

El PER previsto actual de Relx PLC (RELX) es 15.06, frente a su media de 5 años de 21.61.

PER previsto

Valor razonable
Media 5A P/E
21.61
P/E actual
15.06
Sobrevalorada
29.42
Infravalorada
13.80

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
16.85
EV/EBITDA actual
15.18
Sobrevalorada
19.05
Infravalorada
14.65

Precio/ventas previsto

Valor razonable
Media 5A P/S
5.88
P/S actual
6.21
Sobrevalorada
6.72
Infravalorada
5.03

Escenarios de precio de Alphio AI para RELX

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%RELX

$67.03

Precio del escenario

B

Base

Base · 50%RELX

$63.88

Precio del escenario

B

Bajista

Bajista · 25%RELX

$63.25

Precio del escenario

Ballenas con RELX en cartera

R

RBC Europe Limited

+ Con en carteraRELX

+11.89%

Rentabilidad a 3 meses

M

Mawer Investment Management Ltd.

+ Con en carteraRELX

+10.13%

Rentabilidad a 3 meses

Q

Quintet Asset Management S.A.

+ Con en carteraRELX

+8.10%

Rentabilidad a 3 meses

M

Mercer Investments LLC

+ Con en carteraRELX

+7.44%

Rentabilidad a 3 meses

S

SAFE Investment Company Limited

+ Con en carteraRELX

+6.60%

Rentabilidad a 3 meses

C

CCLA Investment Management Limited

+ Con en carteraRELX

+6.35%

Rentabilidad a 3 meses

Preguntas frecuentes sobre RELX, respondidas por Alphio AI

RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).

RELX PLC is a good buy right now due to its strong revenue growth of 3% year-over-year, a current price of $39.06, and a forward P/E ratio of 15.06, which suggests it is attractively valued compared to its earnings potential. The RSI is at 95.901, indicating strong momentum, while hedge funds are increasing their positions by 147.40%, reflecting positive sentiment. The main risk is the 1-year change of -15.29%, which indicates past underperformance that investors should consider.

1 analysts cover RELX: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 60.54.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar